Amgen Got `Awesome Price' for Onyx: Brean's Mack

Aug. 26 (Bloomberg) -- Dr. Celine Gounder, a primary care physician, and Brean Capital's Gene Mack discuss Amgen's purchase of Onyx Pharmaceuticals. They speak with Carol Massar on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
The Benefits of EMV Credit Card Chip Technology
36:42 - Ellen Richey, Visa's chief enterprise risk officer, explains the benefits of EMV credit card chip technology. She speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • ‘The Martian’: $108 Million Movie Debuts This Weekend
  • What’s Behind the Labor Market is Slow Down?
  • How GE Is Appealing to the Tech Audience